Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.23.2
Equity (Details) - USD ($)
shares in Thousands, $ in Millions
 1 Months Ended 6 Months Ended
Aug. 31, 2020
Jun. 30, 2023
Jun. 30, 2022
Equity (Details) [Line Items]      
Expected life   6 years  
Restricted Stock Units [Member]      
Equity (Details) [Line Items]      
Unrecognized compensation expense   $ 1.4  
Fair value   $ 2.0  
Expected term year   2 years 2 months 12 days  
Compensation expense   $ 0.3  
Stock Options [Member]      
Equity (Details) [Line Items]      
Grant of stock options to employees (in Shares)   151  
Exercise price ranging, description   $8.05 to $11.60  
Stock option term   10 years  
Vesting period of stock option   4 years  
Aggregate fair value   $ 1.0  
Unrecognized compensation expense   $ 9.0  
Weighted average term   3 years  
Compensation expense related to stock options   $ 1.7 $ 0.8
Discount rate, description   3.5% to 4.21%  
Expected volatility rate, description   81.1% to 81.6%  
Capital on Demand Sales Agreement [Member]      
Equity (Details) [Line Items]      
Aggregate value of common stock $ 200.0    
Sale of common stock, shares (in Shares)   1,300 2,700
Gross proceeds   $ 10.9 $ 17.2
Net proceeds   $ 10.6 $ 16.7